Assessments of Serum level Vitamin D and Thyroid Function Tests among Newly Diagnosed Female Breast Cancer Patients attending in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
| dc.contributor.advisor | Edao, Abebe | |
| dc.contributor.advisor | Alem, Mekdes | |
| dc.contributor.advisor | Hailu, Habteyes (PhD) | |
| dc.contributor.author | Meles, Mehari | |
| dc.date.accessioned | 2025-08-27T11:37:03Z | |
| dc.date.available | 2025-08-27T11:37:03Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Background: Breast cancer (BC) is the most common cancer in women, with high global mortality. Vitamin D deficiency and thyroid dysfunction may influence BC through hormonal regulation and immune modulation. Thyroid hormones affect cell metabolism and proliferation, while vitamin D has anti-proliferative effects on breast tissue. Thyroid dysfunction can alter estrogen metabolism, impacting BC risk. However, data on serum vitamin D and thyroid hormone levels in Ethiopian BC patients are limited. This study aims to assess these levels in newly diagnosed female BC patients. Methods: A Facility-based comparative cross-sectional study was conducted from January to March 2024 in Tikur Anbessa Specialty Hospital. A convenient sampling method was employed to recruit 69 females newly diagnosed with breast cancer as a case group and 69 samples from apparently healthy females as a control group. Blood samples were collected and sent to Ethiopian Public Health Institute (EPHI) for Serum 25 hydroxyl vitamin D (25(HO) D) Concentration and Thyroid Function Tests , by using a COBAS 6000 analyzer. The data was analyzed using SPSS version 20.0 software. Independent T-tests, chi-square test, One-way ANOVA tests, Kruskal Wallis test, and multiple linear regression tests were used to analyze the data. Results: Breast cancer patients had significantly lower Total Triiodothyronine (TT3) levels(1.2±0.28 ng/mL) than healthy controls (1.4±0.19 ng/mL, p<0.001). Free Triiodothyronine (FT3) was also significantly reduced in BC patients (p< 0.001). 25(HO) D levels showed a significant lower median value in BC patients compared to healthy control groups (p=0.043). Breast cancer stage and subtype significantly influence thyroid function and vitamin D levels, with advanced stages associated with altered thyroid hormones and reduced 25(OH) D levels. Conclusion: Breast Cancer patients exhibited significantly lower TT3 and FT3 levels compared to controls. Although vitamin D deficiency was prevalent in both groups, severe deficiency (<10 ng/mL) was significantly higher in the BC patients. Therefore, monitoring and managing vitamin D and thyroid hormone levels could be important components of breast cancer risk assessment and prevention strategies. However, larger-scale studies are needed to further validate and strengthen these findings. | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/7155 | |
| dc.language.iso | en_US | |
| dc.publisher | Addis Ababa University | |
| dc.subject | Breast Cancer | |
| dc.subject | Thyroid Hormones | |
| dc.subject | TSH | |
| dc.subject | 25(OH) D | |
| dc.subject | Vitamin Deficiency | |
| dc.title | Assessments of Serum level Vitamin D and Thyroid Function Tests among Newly Diagnosed Female Breast Cancer Patients attending in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia | |
| dc.type | Thesis |